跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe
Approved
STANDARD
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe
Roche Products Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
88fc36b6a75650f1
Company
Roche Products Pty Ltd
Type
Standard
Approval Details
Approval Id
88fc36b6a75650f1
Product Name
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe
Artg Id
449965
Artg Name
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe
Sponsor
Roche Products Pty Ltd
Company Detail Path
/organization/roche-products-pty-ltd
Artg Date
2024-09-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/256a18e3ed8ea04be068ff2bea24e347.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5960742f9895155990799d7ad9b3e495.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
88fc36b6a75650f1
Type
Standard
Back to TGA Approvals